CELLULAR IMMUNOTHERAPY • CANCER CARE
Immune Cell Expansion Therapy for Cancer
Immune Cell Expansion Therapy for Cancer at Jeevasa USA is a personalized cellular immunotherapy approach considered for carefully evaluated patients with selected cancer conditions. The patient’s immune cells are collected, processed and expanded in a specialized laboratory before being administered under medical supervision, where clinically appropriate.
Explore Your Treatment Options
Speak with our regenerative medicine team to understand whether Stem Cell Therapy may be suitable for your condition.
Understanding Cancer
and Immune Response
Cancer is a broad group of diseases in which abnormal cells grow beyond normal boundaries and may invade nearby tissues or spread to other parts of the body. The type of cancer, stage, biological characteristics, previous treatment and overall health all influence the care pathway.
The immune system naturally identifies and responds to abnormal or harmful cells. However, cancer cells may develop mechanisms that help them avoid immune recognition or weaken the immune response. Cancer immunotherapy aims to support or improve the immune system’s ability to respond to cancer.
Immune Function
Cancer Diagnosis
Coordinated Care
Comprehensive Cancer Care Goes
Beyond the Diagnosis
Cancer care involves more than addressing the tumour alone. A comprehensive approach also considers immune health, treatment tolerance, physical strength, nutrition, emotional well-being and quality of life throughout the patient’s care journey.
- Supporting the body’s natural defence
- Helping maintain mobility & endurance
- Addressing appetite, nourishment & weakness.
- Helping maintain function across routine
Explore Your Treatment Options
Speak with our regenerative medicine team to understand whether Stem Cell Therapy may be suitable for your condition.
Could Immune Cell Expansion Therapy Be Appropriate for Cancer?
At Jeevasa USA, Immune Cell Expansion Therapy may be considered only after a detailed review of the patient’s cancer diagnosis, pathology, imaging, treatment history, current medicines, immune status and overall health. Suitability cannot be determined from the diagnosis alone.
The therapy should not automatically be viewed as a replacement for surgery, chemotherapy, radiation therapy, targeted therapy or prescribed immunotherapy.
Individual Evaluation
Review of diagnosis, pathology, imaging and medical history.
Personalized Care Plan
Recommendations developed around individual clinical circumstances
Cell Expansion Therapy
Explored where clinically appropriate under specialist supervision
Long-Term Cancer Care
Ongoing monitoring alongside the patient’s wider cancer care.
Common Challenges During Cancer Care
Persistent Fatigue
Appetite Changes
Physical Weakness
Pain or Discomfort
Immune Changes
Emotional Stress
Daily Limitations
Your Journey With Jeevasa
Consultation
Advanced Evaluation
Treatment Plan
Stem Cell Therapy
Recovery Support
Long-Term Follow-Up
Why Patients Choose Jeevasa for Cancer Care
Research Driven Process
Advancing regenerative medicine through innovation.
Experienced Medical Team
Multidisciplinary professionals for Cancer care
Advanced Technology
Modern facilities supporting safe clinical protocols.
Personalized Care Plan
Care pathways designed around individual goals.
Global Patient Support
Dedicated assistance for patients from India and overseas.
Comprehensive Cancer Care
Supporting body’s natural defence and response mechanisms.
Conditions We Also Support
FAQ
What is Immune Cell Expansion Therapy for Cancer?
Immune Cell Expansion Therapy is a cellular immunotherapy approach in which selected immune cells are collected, expanded in a laboratory and administered under medical supervision. Suitability depends on the patient’s diagnosis, health and clinical circumstances.
How does Immune Cell Expansion Therapy work?
The general process involves collecting immune cells, increasing their number under controlled laboratory conditions and administering the prepared cells back to the patient. The exact process depends on the treatment protocol.
Is Immune Cell Expansion Therapy the same as chemotherapy?
No. Chemotherapy uses medicines that affect rapidly dividing cells, while cellular immunotherapy involves immune cells or immune-based mechanisms. They may have different roles and should not be treated as interchangeable.
Does Immune Cell Expansion Therapy replace conventional cancer treatment?
Not automatically. It should not be presented as a general replacement for surgery, chemotherapy, radiation, targeted treatment or prescribed immunotherapy. Clinical coordination with the oncology team is essential.
Who may be eligible for Immune Cell Expansion Therapy?
Eligibility depends on the cancer type, stage, pathology, treatment history, immune status, organ function and overall health. A detailed specialist assessment is required
View all FAQ
What reports are required for an initial evaluation?
Patients may be asked to provide pathology reports, imaging, recent blood tests, treatment summaries, medication details and information about previous surgery, chemotherapy or radiation.
Is Immune Cell Expansion Therapy suitable for every cancer?
No. Different cancers respond differently to immune-based treatments, and not every patient is suitable. The exact therapy and intended use must be evaluated individually.
Can international patients apply for an evaluation?
Yes. International patients can submit available medical records for initial review before planning travel to Jeevasa Hospitals in Mohali, Chandigarh Tricity, India.
Are there possible risks or side effects?
Immune-based treatments can cause side effects, and the risks depend on the specific therapy and the patient’s health. Some immunotherapies may cause the activated immune system to affect healthy tissues, which is why specialist supervision is necessary.
How can I request a consultation?
Complete the website enquiry form and share the available diagnosis, pathology, imaging and treatment records. The clinical team can then advise whether further assessment is appropriate.
View all FAQ
Trusted by Patients Worldwide
25+
Years of Research & Clinical Experience
10,000+
Patients Supported Worldwide
15+
Countries Served
Research
Institute of Longevity Research